Adar Poonawalla Partners with Trivitron to Expand MyLab Globally
Serum Institute of India in Talks to Expand MyLab Discovery Solutions Internationally
Mumbai: The Serum Institute of India Pvt. Ltd, led by Adar Poonawalla, is in discussions with medical device maker Trivitron Healthcare to form a partnership. This potential alliance aims to increase the investment in MyLab Discovery Solutions Pvt. Ltd, a diagnostics provider based in Pune.
According to three individuals familiar with the matter, the partnership will enable Serum Institute of India to expand MyLab Discovery Solutions' operations on a global scale. While further details on the proposed partnership are not yet available, the move is seen as a strategic move to increase the reach of the diagnostics provider.
The Serum Institute of India, led by Adar Poonawalla, is one of the largest vaccine manufacturers in the world, and this move is expected to bolster the company's presence in the diagnostics sector. The partnership with Trivitron Healthcare will likely have a significant impact on the global diagnostics market, with MyLab Discovery Solutions expanding its operations into new territories.
Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data
| Company | Current Status | Proposed Expansion |
|---|---|---|
| MyLab Discovery Solutions Pvt. Ltd | Currently operational in India | Expected to expand internationally |
Note: The table above highlights the current status and proposed expansion of MyLab Discovery Solutions Pvt. Ltd. The exact details of the expansion are not yet available.
Investor Takeaway
Investors should keep an eye on the potential expansion of MyLab Discovery Solutions globally.
More in Market

Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Indian Stocks to Watch: BHEL, Agarwal Industrial, JBM Auto, Rajesh Exports, Indian Energy Exchange, Lenskart Solutions in Market Focus on June 4.
